On their first earnings call since SpaceX's June public offering, executives said the company is pouring funds into rocket development, Starlink satellites and AI.

SpaceX's revenue nearly doubled, the rocket company ​said in its first earnings report since going public, fueled by its booming Starlink satellite communications and AI businesses, but executives flagged the spending spree underpinning its lofty ambitions ‌is far from over.

SpaceX blew past expectations for its first earnings report as a public company. But the company continued to burn through cash in pursuit of CEO Elon Musk’s vision for an AI-powered, Mars-colonizing future.

U.S. stock futures were higher amid a flurry of earnings reports from major companies

Nvidia stock has lagged behind the PHLX Semiconductor Index, which is up 61% this year so far through Monday’s close.

Alphabet recently started selling custom AI chips called Tensor Processing Units (TPUs) directly to customers for use in external data centers. Gil Luria at D.A. Davidson estimates Alphabet could capture 20% of the AI infrastructure in the future if it leans into external sales of TPU systems.

Nvidia is weighing more than $750 billion in AI investments, financing deals and partnerships — betting that any growth in the compute market will ultimately benefit its chip business.Why it matters: The world's most valuable chip company is bankrolling the same customers racing to build alternatives to its chips.

Nvidia Corporation rides the AI capex boom but faces peak-cycle risks, circular financing credit exposure, and rich valuation. Click for more on NVDA stock.

U.S. job openings dropped in June amid a sharp decline in the healthcare and social assistance sector, but a rise in ​hiring and low layoffs suggested the labor market remained stable.

US job openings eased in June but hiring picked up slightly, indicating relatively steady demand for workers heading into the summer.

Some 7.4 million positions were available at the beginning of the summer, compared to 7.2 million in June 2025, according to the Job Openings and Labor Turnover Survey (JOLTS) from the Bureau of Labor Statistics released Tuesday.

U.S. job openings fell slightly in June, but the labor market continued to show resilience in the face of an economic shock from Iran war

Shares of Advanced Micro Devices are down 7.9% in after-hours trading, and to one analyst, it looks like "a classic 'sell the news' moment for an AI-chip stock priced for perfection." Investors wanted proof that AMD's next growth drivers are "arriving faster and cleaner than already assumed,

Key Takeaways Advanced Micro Devices shares slid in extended trading Tuesday, despite quarterly results that topped analysts’ estimates. AMD’s revenue outlook also topped Street projections, though its gross margin forecast was roughly in line.

AMD had long been the second choice for CPU chips behind Intel, and the same for its GPUs, which trail Nvidia’s chips. AMD’s server CPUs are now considered better than Intels

AMD shares fell nearly 9% in after-hours trading despite beating Q2 expectations with $11.54 billion revenue. Strong data center performance drove growth. Here's why the stock fell.

A rally across global stock markets continued, with sentiment boosted by the prospect of a U.S.-Iran agreement to reopen the Strait of Hormuz.

US Secretary of State Marco Rubio and Treasury Secretary Scott Bessent both announced talks had progressed to allow shipments to resume.

Crude futures fell to a three-week low after Treasury Secretary Scott Bessent said the U.S. could be close to an agreement with Iran to reopen the Strait of Hormuz, while Qatar reported progress in diplomatic efforts.

Oil prices turned sharply lower on Tuesday after a Qatari official talked about a potential short-term deal between the U.S. and Iran.

Novo Nordisk hikes its 2026 outlook, but investors focus more on quarterly sales of the Danish pharma giant's Wegovy weight loss pill, which came in slightly lower than expected. CEO Mike Doustdar addresses the expectations in a first on CNBC interview with Carolin Roth.

Novo Nordisk CEO Mike Doustdar faces investors and analysts on Wednesday under pressure to restore confidence in ​the drugmaker's longer-term growth prospects after an upgraded 2026 outlook failed ‌to reassure markets.

The Bagsvaerd, Denmark-based company said it had profit of 74 cents per share. Earnings, adjusted for non-recurring costs, were 96 cents per share. The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 82 cents per share.

Wall Street isn't convinced the Ozempic maker has a promising path back to sustainable growth as competition from Eli Lilly intensifies.